Cigna Group $CI Shares Sold by DRW Securities LLC

Key Points

• DRW Securities LLC reduced its stake in Cigna Group by 58.3% during the first quarter, holding 1,205 shares worth $396,000 after selling 1,688 shares.
• Cigna Group reported $7.20 earnings per share for the latest quarter, exceeding expectations, with a revenue of $67.13 billion, up 11% from the previous year.
• The company announced a quarterly dividend of $1.51 per share, with a yield of 2.0%, and the payout ratio currently stands at 32.97%.

DRW Securities LLC reduced its position in shares of Cigna Group (NYSE:CI - Free Report) by 58.3% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,205 shares of the health services provider's stock after selling 1,688 shares during the period. DRW Securities LLC's holdings in Cigna Group were worth $396,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors have also modified their holdings of the company. Family Legacy Inc. lifted its stake in Cigna Group by 0.5% during the 1st quarter. Family Legacy Inc. now owns 6,497 shares of the health services provider's stock worth $2,138,000 after acquiring an additional 31 shares in the last quarter. Impact Investors Inc increased its stake in Cigna Group by 1.6% during the first quarter. Impact Investors Inc now owns 1,975 shares of the health services provider's stock worth $650,000 after purchasing an additional 31 shares during the period. Mission Wealth Management LP boosted its stake in shares of Cigna Group by 1.5% in the first quarter. Mission Wealth Management LP now owns 2,101 shares of the health services provider's stock valued at $691,000 after purchasing an additional 32 shares during the period. Westend Capital Management LLC grew its holdings in shares of Cigna Group by 8.1% in the first quarter. Westend Capital Management LLC now owns 427 shares of the health services provider's stock valued at $140,000 after purchasing an additional 32 shares in the last quarter. Finally, Moody National Bank Trust Division grew its holdings in shares of Cigna Group by 0.7% in the first quarter. Moody National Bank Trust Division now owns 4,587 shares of the health services provider's stock valued at $1,509,000 after purchasing an additional 34 shares in the last quarter. 86.99% of the stock is owned by institutional investors and hedge funds.

Cigna Group Stock Up 0.4%

Shares of CI traded up $1.25 during mid-day trading on Friday, reaching $305.28. The company's stock had a trading volume of 1,157,697 shares, compared to its average volume of 1,520,955. The company has a debt-to-equity ratio of 0.65, a current ratio of 0.71 and a quick ratio of 0.71. Cigna Group has a 12-month low of $256.89 and a 12-month high of $370.83. The stock has a market cap of $81.49 billion, a PE ratio of 16.66, a price-to-earnings-growth ratio of 0.89 and a beta of 0.48. The company's 50 day moving average is $297.68 and its 200 day moving average is $312.17.

Cigna Group (NYSE:CI - Get Free Report) last posted its earnings results on Thursday, July 31st. The health services provider reported $7.20 earnings per share for the quarter, topping the consensus estimate of $7.15 by $0.05. The firm had revenue of $67.13 billion during the quarter, compared to analysts' expectations of $62.61 billion. Cigna Group had a return on equity of 18.80% and a net margin of 1.92%.The firm's revenue was up 11.0% compared to the same quarter last year. During the same quarter in the previous year, the business earned $6.72 earnings per share. Cigna Group has set its FY 2025 guidance at 29.600- EPS. Equities analysts anticipate that Cigna Group will post 29.77 EPS for the current fiscal year.

Cigna Group Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, September 18th. Stockholders of record on Thursday, September 4th will be issued a $1.51 dividend. The ex-dividend date is Thursday, September 4th. This represents a $6.04 annualized dividend and a dividend yield of 2.0%. Cigna Group's dividend payout ratio is presently 32.97%.

Insider Activity at Cigna Group

In related news, insider Nicole S. Jones sold 28,526 shares of Cigna Group stock in a transaction on Friday, August 15th. The shares were sold at an average price of $300.00, for a total transaction of $8,557,800.00. Following the sale, the insider directly owned 25,648 shares in the company, valued at $7,694,400. This trade represents a 52.66% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 0.70% of the stock is owned by company insiders.

Analysts Set New Price Targets

CI has been the subject of several recent research reports. Guggenheim reissued a "buy" rating and issued a $350.00 price target (down previously from $388.00) on shares of Cigna Group in a research report on Monday, August 4th. Barclays increased their price objective on Cigna Group from $354.00 to $383.00 and gave the company an "overweight" rating in a research note on Thursday. Robert W. Baird set a $372.00 target price on Cigna Group in a report on Thursday, August 14th. Deutsche Bank Aktiengesellschaft set a $415.00 price target on Cigna Group and gave the stock a "buy" rating in a report on Tuesday, August 5th. Finally, Truist Financial set a $375.00 price target on Cigna Group in a research report on Tuesday, September 2nd. Two analysts have rated the stock with a Strong Buy rating, fifteen have given a Buy rating and two have assigned a Hold rating to the company's stock. According to MarketBeat.com, the stock currently has a consensus rating of "Buy" and a consensus target price of $374.76.

Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.